Results 81 to 90 of about 999 (168)

Carbocysteine lysine salt monohydrate (SCMC-LYS) is a selective scavenger of reactive oxygen intermediates (ROIs)

open access: yes, 2003
: Carbocysteine lysine salt monohydrate (SCMC-Lys) is a well-known mucoactive drug whose therapeutic efficacy is commonly related to the ability of SCMC-Lys to replace fucomucins by sialomucins.
Mengozzi, Manuela   +9 more
core   +1 more source

Multiple fixed drug eruption due to carbocysteine: Presence of circulating interferon-γ-producing CD8+ T cells reactive with its night metabolite thiodiglycolic acid

open access: yesAllergology International, 2022
Hiroki Morimoto   +7 more
doaj   +1 more source

Antioxidants and Mucolytics in COPD Management: When (if ever) and in Whom?

open access: yes, 2013
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. Oxidative stress is an important mechanism in the pathogenesis of this disease.
Hillas, Georgios   +3 more
core   +1 more source

Allergic bronchopulmonary mycosis caused by <i>Schizophyllum commune</i> in a patient with severe food allergy and asthma. [PDF]

open access: yesIDCases
Ohkoshi Y   +7 more
europepmc   +1 more source

Pneumonic Injury and Repair: A Synopsis. [PDF]

open access: yesPharmaceuticals (Basel), 2023
Barabutis N.
europepmc   +1 more source

RICERCA POLICENTRICA SU UNA LARGA CASISTICA DI PAZIENTI OSPEDALIZZATI,AFFETTI DA BPCO IN FASE DI RIACUTIZZAZIONE,TRATTATI CON L'ASSOCIAZIONE CARBOCISTEINA-SOBREROLO

open access: yes, 1988
AN OPEN STUDY INVOLVED 14 ITALIAN CENTERS AND 348 HOSPITALIZED PATIENTS OF BOTH SEXES, AGED 61.57 +- 12.54 (MEAN VALUE) WITH COPD IN ACUTE PHASE. ALL PATIENTS WERE TREATED WITH YHE CARBOCYSTEINE AND SOBREROL COMBINATION FOR 10 CONSECUTIVE DAYS.
CASCIATO G   +37 more
core  

Airway mucus in infection. [PDF]

open access: yesFront Physiol
Costello C, Birket S.
europepmc   +1 more source

Home - About - Disclaimer - Privacy